# NEURONTIN
> **NDA021129** · New Drug Application · Sponsor: VIATRIS · Approved 2000-03-02
## Drug
- **FDA Application Number:** NDA021129
- **Application type:** New Drug Application
- **Brand name:** NEURONTIN
- **Generic name:** GABAPENTIN
- **Active ingredients:** GABAPENTIN
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** VIATRIS
- **Manufacturer:** Parke-Davis Div of Pfizer Inc
- **First approval:** 2000-03-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021129)
---
*AI Analytics · CC0 1.0*